Actuate Therapeutics IncACTUNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank0
3Y CAGR-10.2%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-10.2%/yr
Annual compound
Percentile
P0
Near historical low
vs 3Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$11.85M-36.6%
2024$18.68M-14.0%
2023$21.71M+32.5%
2022$16.39M-